Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icariin for Acne and Acne Scars
NCT07076784Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Trial of icariin in acne vulgaris and acne scars (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change from baseline in the total number of acne lesions and scars at 8 weeks. Started Mar 2023; status: completed.
02
Drugs
icariin
03
Conditions
acne vulgarisacne scars
Beyond the preview
Go deeper on NCT07076784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07076784.